# US 2004/0081702 A1 · Bee venom treatment without the sting

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081702 A1
- Document ID: US20040081702A1
- Status: Published application
- Kind: A1
- Application number: 10/690,772
- Filed: 2003-10-22
- Published: 2004-04-29
- Earliest claimed: 2000-04-14
- Inventors: Christopher M. Kim
- Web page: https://patentgrep.com/patent/US20040081702A1

## CPC

- A61K 38/47: acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 35/63: Arthropods (aquatic crustaceans A61K35/612)
- A61K 38/1767: {from invertebrates}
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 23/02: Local anaesthetics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Bee venom may be administered in a standardized formulation with or without relatively small amounts of anesthetic. In particular, the results of the combination of venom and anesthetic dramatically decreased pain and discomfort for patients undergoing apitherapy.

## Claims

### Claim 1

A pharmaceutical compound comprising:
a therapeutically effective amount of bee venom; and
at least one anesthetic provided in an amount which is sufficient to reduce the irritation associated with the injection of said bee venom.

### Claim 2 (depends on 1)

The pharmaceutical compound of claim 1 wherein said anesthetic is provided in a ratio of between about 20:1-1:10 by weight relative to the weight of said bee venom.

### Claim 3 (depends on 2)

The pharmaceutical compound of claim 2 wherein said anesthetic is provided in a ratio of between about 10:1-1:5 by weight relative to the weight of said bee venom.

### Claim 4 (depends on 3)

The pharmaceutical compound of claim 3 wherein said anesthetic is provided in a ratio of between about 3:1-1:1 by weight relative to the weight of said bee venom.

### Claim 5 (depends on 1, 2, 3, 4)

The pharmaceutical compound of claims 1, 2, 3 or 4 further comprising at least one excipient or liquid carrier.

### Claim 6 (depends on 5)

The pharmaceutical compound of claim 5 wherein said at least one excipient or liquid carrier are provided in an amount which is sufficient to provide between about 0.1 mg and about 10 mg of bee venom per mL.

### Claim 7 (depends on 6)

The pharmaceutical compound of claim 6 wherein said at least one excipient or liquid carrier are provided in an amount which is sufficient to provide between about 0.5 mg and about 5.0 mg of bee venom per mL.

### Claim 8 (depends on 7)

The pharmaceutical compound of claim 7 wherein said at least one excipient or liquid carrier are provided in an amount which is sufficient to provide about 1 mg of bee venom per mL.

### Claim 9 (depends on 8)

The pharmaceutical compound of claim 8 wherein said at least one anesthetic is a local anesthetic.

### Claim 10 (depends on 9)

The pharmaceutical compound of claim 9 wherein said local anesthetic is lidocaine.

### Claim 11

A standardized bee venom preparation suitable for administration by injection comprising: a liquid carrier and admixed therein between about 0.1 mg to about 10.0 mg by weight of bee venom per mL of said liquid carrier, said preparation being filtered though a 25 mcm filter.

### Claim 12 (depends on 11)

The standardized bee venom preparation of claim 11 further comprising at least one anesthetic provided in an amount which is sufficient to reduce the irritation associated with the injection of said bee venom.
